Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/12/2025

Management of Medication-Induced Hyperprolactinemia

Treatment Options

  • The Centers for Disease Control and Prevention recommends that Oral Contraceptive Pills (OCPs) can be started at any time if it is reasonably certain the woman is not pregnant, and for women with amenorrhea, back-up contraception is needed for the first 2 days after starting OCPs 1, 2
  • The Centers for Disease Control and Prevention suggests that when using OCPs in a patient with medication-induced hyperprolactinemia, standard OCP monitoring protocols should be followed 1, 2